These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29513538)

  • 21. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained-release amorphous solid dispersions.
    Maincent J; Williams RO
    Drug Deliv Transl Res; 2018 Dec; 8(6):1714-1725. PubMed ID: 29498004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supersaturation and phase behavior during dissolution of amorphous solid dispersions.
    Kong Y; Wang W; Wang C; Li L; Peng D; Tian B
    Int J Pharm; 2023 Jan; 631():122524. PubMed ID: 36549404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization.
    Moseson DE; Corum ID; Lust A; Altman KJ; Hiew TN; Eren A; Nagy ZK; Taylor LS
    AAPS J; 2021 May; 23(4):69. PubMed ID: 34002256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Counterions on Dissolution of Amorphous Solid Dispersions Studied by Surface Area Normalized Dissolution.
    Chen Y; Lubach JW; Tang S; Narang AS
    Mol Pharm; 2021 Sep; 18(9):3429-3438. PubMed ID: 34338529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers.
    Saboo S; Moseson DE; Kestur US; Taylor LS
    Eur J Pharm Sci; 2020 Dec; 155():105514. PubMed ID: 32810579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
    Faiz Afzal MA; Lehmkemper K; Sobich E; Hughes TF; Giesen DJ; Zhang T; Krauter CM; Winget P; Degenhardt M; Kyeremateng SO; Browning AR; Shelley JC
    Mol Pharm; 2021 Nov; 18(11):3999-4014. PubMed ID: 34570503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation.
    Qi Q; Taylor LS
    Int J Pharm; 2022 Jun; 622():121886. PubMed ID: 35661745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Visualization of Drug-Polymer Phase Separation in Ritonavir-Copovidone Amorphous Solid Dispersions Using
    Shi C; Li L; Zhang GGZ; Borchardt TB
    Mol Pharm; 2019 Nov; 16(11):4751-4754. PubMed ID: 31553871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion.
    Gao D; Zhu D; Zhou X; Dong S; Chen Y
    Mol Pharm; 2023 Jan; 20(1):409-418. PubMed ID: 36529939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
    Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
    Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption.
    Kawakami K; Sato K; Fukushima M; Miyazaki A; Yamamura Y; Sakuma S
    Eur J Pharm Biopharm; 2018 Nov; 132():146-156. PubMed ID: 30253186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
    Yang Z; Nollenberger K; Albers J; Qi S
    Mol Pharm; 2014 Jul; 11(7):2453-65. PubMed ID: 24897345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoscale Infrared, Thermal, and Mechanical Characterization of Telaprevir-Polymer Miscibility in Amorphous Solid Dispersions Prepared by Solvent Evaporation.
    Li N; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):1123-36. PubMed ID: 26859046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
    Hiew TN; Zemlyanov DY; Taylor LS
    Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport.
    Wilson V; Lou X; Osterling DJ; Stolarik DF; Jenkins G; Gao W; Zhang GGZ; Taylor LS
    J Control Release; 2018 Dec; 292():172-182. PubMed ID: 30408553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.